Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Immunopathogenesis and treatment of cytokine storm in COVID-19

    Research output: Contribution to journalReviewResearchpeer-review

  2. In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Remote loading of liposomes with a 124I-radioiodinated compound and their in vivo evaluation by PET/CT in a murine tumor model

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. ANGPTL4: a new mode in the regulation of intravascular lipolysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Glioblastoma (GBM) is a devastating cancer with basically no curative treatment. Even with aggressive treatment, the median survival is disappointing 14 months. Surgery remains the key treatment and the postoperative survival is determined by the extent of resection. Unfortunately, the invasive growth with irregular infiltrating margins complicates an optimal surgical resection. Precise intraoperative tumor visualization is therefore highly needed and molecular targeted near-infrared (NIR) fluorescence imaging potentially constitutes such a tool. The urokinase-type Plasminogen Activator Receptor (uPAR) is expressed in most solid cancers primarily at the invading front and the adjacent activated peritumoral stroma making it an attractive target for targeted fluorescence imaging. The purpose of this study was to develop and evaluate a new uPAR-targeted optical probe, IRDye800CW-AE344, for fluorescence guided surgery (FGS). Methods: In the present study we characterized the fluorescent probe with regard to binding affinity, optical properties, and plasma stability. Further, in vivo imaging characterization was performed in nude mice with orthotopic human patient derived glioblastoma xenografts, and we performed head-to-head comparison within FGS between our probe and the traditional procedure using 5-ALA. Finally, the blood-brain barrier (BBB) penetration was characterized in a 3D BBB spheroid model. Results: The probe effectively visualized GBM in vivo with a tumor-to-background ratio (TBR) above 4.5 between 1 to 12 h post injection and could be used for FGS of orthotopic human glioblastoma xenografts in mice where it was superior to 5-ALA. The probe showed a favorable safety profile with no evidence of any acute toxicity. Finally, the 3D BBB model showed uptake of the probe into the spheroids indicating that the probe crosses the BBB. Conclusion: IRDye800CW-AE344 is a promising uPAR-targeted optical probe for FGS and a candidate for translation into human use.

Original languageEnglish
JournalTheranostics
Volume11
Issue number15
Pages (from-to)7159-7174
Number of pages16
ISSN1838-7640
DOIs
Publication statusPublished - 2021

    Research areas

  • optical imaging, fluorescence-guided surgery, glioblastoma, uPAR, molecular targeted imaging, Neoplasm Transplantation, Optical Imaging, Humans, Peptides/chemistry, Indoles/chemistry, Glioblastoma/diagnostic imaging, Animals, Heterografts, Neoplasms, Experimental/diagnostic imaging, Cell Line, Tumor, Mice, Receptors, Urokinase Plasminogen Activator/metabolism, Neoplasm Proteins/metabolism

ID: 66418016